补虚平喘膏如何改善COPD？CAT评分与mMRC分级双指标验证

The COPD Assessment Test (CAT) score is used to evaluate the quality of life in patients with COPD, encompassing eight aspects: cough, sputum production, chest tightness, breathlessness, daily activities, confidence in leaving home, sleep, and energy levels. Higher scores indicate a greater impact of COPD on an individual's daily life. This study shows that the CAT scores of both groups significantly decreased after treatment, with the experimental group showing a more significant improvement compared to the control group. This indicates that Bu Xu Ping Chuan膏 (a traditional Chinese medicine) can effectively alleviate clinical symptoms such as cough, sputum production, and breathlessness, thereby improving the patients' quality of life. The Modified Medical Research Council (mMRC) grading system is a simple and effective tool for evaluating the severity of dyspnea, and its improvement directly reflects an increase in the patient's exercise tolerance. Both groups showed a significant improvement in mMRC grading after treatment, with the experimental group demonstrating better improvement compared to the control group. The reduction in dyspnea in the experimental group patients in this study suggests that Bu Xu Ping Chuan膏 can improve multiple aspects of the patients' quality of life, which aligns well with the holistic approach of Traditional Chinese Medicine (TCM). Modern clinical studies have found that the degree of intestinal dysfunction in COPD patients is positively correlated with CAT and mMRC scores. The more significant the improvement in intestinal symptoms, the less severe the dyspnea, leading to a significant enhancement in quality of life. This finding is consistent with the results of this study, indicating the important role of regulating intestinal function in improving subjective symptoms in COPD patients. It also provides modern clinical evidence supporting the theory of "lung and intestine co-treatment."